Douglas C Bryant Quidel Ortho Corp (QDEL) insider trading activity

Douglas C Bryant is President & CEO of QuidelOrtho Corp. Currently has a direct ownership of 549,415 shares of QDEL, which is worth approximately $21.5 Million. The most recent transaction as insider was on Feb 03, 2024, when has been sold 1,924 shares (Common Stock) at a price of $68.34 per share, resulting in proceeds of $131,486. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 549K

0% 3M change

2.59% 12M change

Total Value Held $21.5 Million

DOUGLAS C BRYANT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 03 2024	SELL Payment of exercise price or tax liability	$131,486 $68.34 p/Share	1,924 Reduced 0.35%	549,415 Common Stock
Feb 03 2024	BUY Grant, award, or other acquisition	-	3,795 Added 0.68%	551,339 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$39,308 $69.45 p/Share	566 Reduced 0.1%	547,544 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	1,116 Added 0.2%	548,110 Common Stock
Jan 31 2024	SELL Payment of exercise price or tax liability	$509,029 $68.51 p/Share	7,430 Reduced 1.34%	546,994 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	18,854 Added 3.3%	551,948 Common Stock
Aug 24 2023	SELL Payment of exercise price or tax liability	$56,789 $78.33 p/Share	725 Reduced 0.14%	535,570 Common Stock
Aug 24 2023	BUY Grant, award, or other acquisition	-	1,461 Added 0.27%	536,295 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$667,720 $88.71 p/Share	7,527 Reduced 1.39%	534,543 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	15,180 Added 2.72%	542,070 Common Stock
Feb 11 2023	SELL Payment of exercise price or tax liability	$392,710 $86.5 p/Share	4,540 Reduced 0.85%	526,890 Common Stock
Feb 11 2023	BUY Grant, award, or other acquisition	-	9,501 Added 1.77%	527,977 Common Stock
Feb 04 2023	SELL Payment of exercise price or tax liability	$832,595 $89.7 p/Share	9,282 Reduced 1.75%	521,929 Common Stock
Feb 04 2023	BUY Grant, award, or other acquisition	-	18,720 Added 3.4%	531,211 Common Stock
Feb 03 2023	SELL Payment of exercise price or tax liability	$168,815 $89.7 p/Share	1,882 Reduced 0.37%	512,491 Common Stock
Feb 03 2023	BUY Grant, award, or other acquisition	-	3,795 Added 0.73%	514,373 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$48,946 $88.51 p/Share	553 Reduced 0.11%	510,578 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	1,115 Added 0.22%	511,131 Common Stock
Jan 31 2023	SELL Payment of exercise price or tax liability	$291,587 $85.61 p/Share	3,406 Reduced 0.66%	510,016 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	6,760 Added 1.3%	513,422 Common Stock
Aug 24 2022	SELL Payment of exercise price or tax liability	$62,119 $85.8 p/Share	724 Reduced 0.14%	506,662 Common Stock
Aug 24 2022	BUY Grant, award, or other acquisition	-	1,460 Added 0.29%	507,386 Common Stock
May 27 2022	BUY Grant, award, or other acquisition	-	505,926 Added 50.0%	505,926 Common Stock

DCB

Douglas C Bryant

President & CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QDEL shares.

Notify only if

Value

Insider Trading

Get notified when an Quidel Ortho Corp insider buys or sells QDEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to QuidelOrtho Corp

Track Activities on QDEL

Account